United Kingdom Pharmaceuticals

Allergy Therapeutics PLC (AGY)

Track

Allergy Therapeutics PLC experienced notable insider activity in February 2026. Non-Executive Director Zheqing Shen executed significant buy orders on February 25, followed by a substantial sale on February 27. These represent the most recent transactions recorded for the firm, occurring over three months ago.
Ticker: AGY Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Allergy Therapeutics PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Mr. Zheqing Shen Non-Executive Director Executive Director
Through ZQ Capital Management Limited, a closely affiliated person
Transaction date
Sale
Price
453.79
Quantity 33,766
Value £862,575
Mr. Zheqing Shen Non-Executive Director Executive Director
Through ZQ Capital Management Limited, a closely affiliated person
Transaction date
Purchase
Price
155.28
Quantity 3,541
Value £1,735,078
Zheqing Shen Non-Executive Director Executive Director
Through ZQ Capital Management Limited, a closely affiliated person
Transaction date
Purchase
Price
352.05
Quantity 14,693
Value £1,709,478
Zheqing (Simon) Shen Non-Executive Director Executive Director
Through SkyGem Acquisition Limited, a closely affiliated person
Transaction date
Purchase
Price
0.01
Quantity 247,935,057
Value £2,479,351
Peter Jensen Non-Executive Chairman, Director Executive Director
Transaction date
Purchase
Price
0.36
Quantity 30,000
Value £10,800
Peter Jensen Non-Executive Chairman, Director Executive Director
Transaction date
Purchase
Price
0.14
Quantity 100,000
Value £14,000
Peter Jensen Non-Executive Chairman, Director Executive Director
Transaction date
Purchase
Price
0.18
Quantity 20,000
Value £3,600
Nick Wykeman Chief Financial Officer, Director Executive Director
Transaction date
Purchase
Price
0.18
Quantity 150,000
Value £26,250
Manuel Llobet Chief Executive Officer, Director Executive Director
Transaction date
Purchase
Price
0.18
Quantity 50,000
Value £8,750
Babatunde (Tunde) Otulana Non-Executive Director Executive Director
Transaction date
Purchase
Price
0.39
Quantity 25,000
Value US$9,700
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-12 2026-02-27 S Sale Mr. Zheqing Shen

Non-Executive Director

Through ZQ Capital Management Limited, a closely affiliated person Executive Director
33,766
453.79
£862,575 		33,766 453.79 £862,575
2026-03-12 2026-02-25 B Purchase Mr. Zheqing Shen

Non-Executive Director

Through ZQ Capital Management Limited, a closely affiliated person Executive Director
3,541
155.28
£1,735,078 		3,541 155.28 £1,735,078
2026-03-12 2026-02-25 B Purchase Zheqing Shen

Non-Executive Director

Through ZQ Capital Management Limited, a closely affiliated person Executive Director
14,693
352.05
£1,709,478 		14,693 352.05 £1,709,478
2023-11-10 2023-11-09 B Purchase Zheqing (Simon) Shen

Non-Executive Director

Through SkyGem Acquisition Limited, a closely affiliated person Executive Director
247,935,057
0.01
£2,479,351 		247,935,057 0.01 £2,479,351
2021-11-11 2021-11-10 B Purchase Peter Jensen

Non-Executive Chairman, Director

Executive Director
30,000
0.36
£10,800 		30,000 0.36 £10,800
2020-11-20 2020-11-19 B Purchase Peter Jensen

Non-Executive Chairman, Director

Executive Director
100,000
0.14
£14,000 		100,000 0.14 £14,000
2018-10-24 2018-10-23 B Purchase Peter Jensen

Non-Executive Chairman, Director

Executive Director
20,000
0.18
£3,600 		20,000 0.18 £3,600
2018-10-24 2018-10-23 B Purchase Nick Wykeman

Chief Financial Officer, Director

Executive Director
150,000
0.18
£26,250 		150,000 0.18 £26,250
2018-10-24 2018-10-23 B Purchase Manuel Llobet

Chief Executive Officer, Director

Executive Director
50,000
0.18
£8,750 		50,000 0.18 £8,750
2018-03-16 2018-03-15 B Purchase Babatunde (Tunde) Otulana

Non-Executive Director

Executive Director
25,000
0.39
US$9,700 		25,000 0.39 US$9,700
Explore more

More insider trading research around Allergy Therapeutics PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe